Here’s what Matt Kaeberlein has revealed thus far concerning the Rapamycin Survey examine (that many people right here participated in final 12 months). Full video of his presentation down on the backside of this put up. Essentially the most attention-grabbing consequence I noticed was that no person within the rapamycin group has reported getting lengthy covid.
These are the unpublished outcomes that give us an early have a look at the examine outcomes; the total examine paper is due out later this 12 months. The outcomes are usually not very totally different from what we’ve seen reported in our customers and consumer polls: Dosing, and Facet Results, and Advantages.
Full Video of his dialogue on this subject under:
10 Likes
Thanks RapAdmin You made a superb overview. All of the meat and it’s concise.
Good synopsis. Was the consumer survey that you just had posted right here used on this examine, or did they do one other survey that had related questions?
I had not heard that he was leaving academia for a startup. Hopefully he continues to put up on Twitter and provides his tackle research and outcomes. His takes are at all times informative and useful.
1 Like
